AB Science CEO Discusses New Early-Treatment Drug For Covid-19 | Interview

Join The Conversation! | https://trialsitenews.com/
Alain Moussy, CEO of AB Science, discusses their new early-treatment drug for COVID-19:

AB Science | https://www.ab-science.com/
Article on drug published in Science | https://www.science.org/doi/10.1126/science.abg5827